Sunwin Stevia International, Inc. (SUWN) Research

Sunwin Stevia International, Inc. (SUWN) is a China-based company specializing in the manufacture and distribution of natural sweetening agents and various pharmaceutical products, primarily serving the People's Republic of China. The company's operations are structured into two principal divisions: Stevioside, and Corporate and Other Pharmaceutical. Under its stevioside segment, Sunwin produces a diverse range of steviol glycoside compounds, with rebaudioside A and stevioside as their key active components. Its product offerings include Steviosin, a low-calorie stevia extract designed for medicinal use, and OnlySweet, a zero-calorie tabletop sweetener. These products are supplied to a broad clientele, encompassing food and drug manufacturers, ingredient distributors, and international trade companies. Additionally, the firm is involved in the production and sale of Metformin, a widely utilized medication for the treatment of type 2 diabetes. Sunwin Stevia International, Inc. maintains its headquarters in Qufu, China.

Open Sunwin Stevia International, Inc. (SUWN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.